Andrew Brackmann
Stock Analyst at William Blair
(4.77)
# 701
Out of 4,453 analysts
152
Total ratings
65.7%
Success rate
28.7%
Average return
Main Sectors:
Stocks Rated by Andrew Brackmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFLY Butterfly Network | Maintained: Buy | n/a | $8.02 | - | 10 | Jun 18, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | n/a | $20.25 | - | 12 | Jun 16, 2026 | |
| DGX Quest Diagnostics | Maintained: Buy | n/a | $206.24 | - | 6 | Jun 15, 2026 | |
| TEM Tempus AI | Reiterated: Hold | n/a | $54.87 | - | 11 | Jun 1, 2026 | |
| NEO NeoGenomics | Maintained: Hold | n/a | $13.73 | - | 11 | May 27, 2026 | |
| CDNA CareDx | Reiterated: Hold | n/a | $27.85 | - | 7 | May 27, 2026 | |
| GH Guardant Health | Maintained: Buy | n/a | $142.94 | - | 14 | May 27, 2026 | |
| MDXH MDxHealth | Downgraded: Hold | n/a | $0.4546 | - | 8 | May 14, 2026 | |
| XGN Exagen | Reiterated: Buy | n/a | $4.64 | - | 7 | May 12, 2026 | |
| NTRA Natera | Maintained: Buy | n/a | $260.74 | - | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.34 | - | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.82 | - | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $112.24 | - | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.52 | - | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $58.55 | - | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.04 | - | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $266.34 | - | 5 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $38.94 | -2.41% | 7 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $93.24 | - | 2 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $151.38 | - | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.80 | n/a | 1 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $5.45 | n/a | 1 | Feb 3, 2022 |
Butterfly Network
Jun 18, 2026
Maintained: Buy
Price Target: n/a
Current: $8.02
Upside: -
Adaptive Biotechnologies
Jun 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.25
Upside: -
Quest Diagnostics
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $206.24
Upside: -
Tempus AI
Jun 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $54.87
Upside: -
NeoGenomics
May 27, 2026
Maintained: Hold
Price Target: n/a
Current: $13.73
Upside: -
CareDx
May 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $27.85
Upside: -
Guardant Health
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $142.94
Upside: -
MDxHealth
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4546
Upside: -
Exagen
May 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.64
Upside: -
Natera
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $260.74
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.34
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $1.82
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $112.24
Upside: -
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $13.52
Upside: -
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $58.55
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $20.04
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $266.34
Upside: -
Apr 28, 2026
Maintained: Hold
Price Target: $38
Current: $38.94
Upside: -2.41%
Jan 23, 2026
Maintained: Buy
Price Target: n/a
Current: $93.24
Upside: -
Aug 8, 2025
Maintained: Hold
Price Target: n/a
Current: $151.38
Upside: -
Oct 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.80
Upside: n/a
Feb 3, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $5.45
Upside: n/a